Seminars in Oncology
Volume 34, Issue 6 , Pages 467-475 , December 2007

Failure of Senescence in the Dysplasia–Melanoma Sequence: Demonstration Using a Tissue Microarray and a Revised Paradigm for Melanoma

  • Ralph J. Tuthill

      Affiliations

    • Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, OH.
    • Corresponding Author InformationAddress correspondence to Ralph J Tuthill, MD, Department of Anatomic Pathology, Desk L25, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195.
    • ,
  • Richard J. Reed

      Affiliations

    • Department of Pathology and Laboratory Medicine, Tulane University, School of Medicine, New Orleans, LA.

References 

  1. Lever WF. Histopathology of the Skin. Philadelphia, PA: Lippincott; 1949;
  2. Masson P. My conception of cellular nevi. Cancer. 1951;4:9–38
  3. Allen A, Spitz S. Malignant melanoma (A clinicopathological analysis of the criteria for diagnosis and prognosis). Cancer. 1953;6:1–45
  4. Horstadius S. The Neural Crest (Its Properties and Derivatives in the Light of Experimental Research). London, UK: Oxford University Press; 1950;
  5. Ewing J. The problems of melanoma. Br Med J. 1930;2:852–856
  6. Rwylin A. Malignant melanoma in light of the multistep theory of neoplasia. Am J Dermatopathol. 1989;11:387–389
  7. Reed RJ. Melanoma in situ: Images, segments, appellations, and implications. Hum Pathol. 1998;29:1–3
  8. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19–20
  9. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–2147
  10. Michaloglou C, Vredeveld LCW, Soengas MS, et al. BRAFe600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436:720–724
  11. Weinberg R. Molecular mechanisms of invasion and metastasis. Pigment Cell Res. 2005;18(suppl 1):3
  12. Bennett D, Medrano EE. Molecular regulation of melanocyte senescence. Pigment Cell Res. 2002;15:242–250
  13. Bennett D. Human melanocyte senescence and melanoma susceptibility genes. Oncogene. 2003;22:3063–3069
  14. Gray-Schopfer V, Cheong SC, Chong H, et al. Cellular senescence in naevi and immortalization in melanoma: A role for p16?. Br J Cancer. 2006;95:496–505
  15. Weinberg R. The Biology of Cancer. New York, NY: Garland Science, Taylor & Francis Group; 2007;
  16. Reed RJ, Ichinose H, Clark WH, et al. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol. 1975;2:119–147
  17. Reed RJ. Minimal deviation melanoma. In:  Mihm MC,  Murphy GF,  Kaufman N editor. Pathobiology and Recognition of Malignant Melanoma. Baltimore, MD: Williams & Wilkins; 1988;p. 110–152
  18. Clark WH, Elder DE, Guerry D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893–1904
  19. Taran J, Heenan P. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer. 2001;91:1822–1825
  20. Karakousis GC, Gimotty PA, Botbyl JD, et al. Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol. 2006;13:533–541
  21. Gupta P, Kuperwasser C, Brunet J-P, et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet. 2005;37:1047–1054
  22. Ruhoy S, Prieto VG, Eliason SL, et al. Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000;24:1600–1614
  23. Mooi W, Peeper D. Oncogene-induced cell senescence–Halting on the road to cancer. N Engl J Med. 2006;355:1037–1046
  24. Lund HZ, Stobbe GD. The natural history of the pigmented nevus; factors of age and anatomic location. Am J Pathol. 1949;25:1117–1155
  25. Helwig E. Malignant melanoma of the skin in man. In:  Urbach F editors. The First International Conference on The Biology of Cutaneous Cancer. Washington, DC: Government Printing Office; 1962;p. 287–295
  26. Goovaerts G, Buyssens N. Nevus cell maturation or atrophy?. Am J Dermatopathol. 1988;10:20–27
  27. Chin L, Garraway LA, Fisher DE. Malignant melanoma: Genetics and therapeutics in the genomic era. Genes Dev. 2006;20:2149–2182
  28. Li W, Sanki A, Karim RZ, et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287–301
  29. Plettenberg A, Ballaun C, Pammer J, et al. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol. 1995;146:651–659

PII: S0093-7754(07)00189-3

doi: 10.1053/j.seminoncol.2007.09.014

Seminars in Oncology
Volume 34, Issue 6 , Pages 467-475 , December 2007

Article Tools

* Image Usage & Resolution